<DOC>
	<DOC>NCT00232167</DOC>
	<brief_summary>The goal of this study is to determine whether indiplon, when administered with sertraline, improves insomnia symptoms and depressive symptoms in subjects with both insomnia and depression.</brief_summary>
	<brief_title>Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression</brief_title>
	<detailed_description>This Pfizer run study stopped due to the co-development program for indiplon being terminated between Pfizer and Neurocrine. The study was terminated on 16 November 2006. There were no safety issues leading to the decision to terminate this study.</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Indiplon</mesh_term>
	<criteria>DSMIV defined insomnia DSMIV defined Major Depression Current suicidal ideation or behavior Primary sleep disorder other than insomnia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>